Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 · New England Journal of Medicine · 2,482 citations
https://doi.org/10.1056/nejmoa2025845
P
Patrick Schloemer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
3.5K
Citations
13
h-index
14
i10-index
Patrick Schloemer is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Hormonal Regulation and Hypertension & Heart Failure Treatment and Management & Diabetes Treatment and Management. The author has an h-index of 13, co-authored 55 publications.
ORCID: 0009-0004-7787-5662Papers by this author
worksDesign and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
2024 · Nephrology Dialysis Transplantation · 63 citations
https://doi.org/10.1093/ndt/gfae132
Finerenone and Kidney Outcomes in Patients With Heart Failure
2024 · Journal of the American College of Cardiology · 54 citations
https://doi.org/10.1016/j.jacc.2024.10.091
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials
2023 · Kidney International · 17 citations
https://doi.org/10.1016/j.kint.2023.03.037
Finerenone Across the Spectrum of Kidney Risk in Heart Failure
2025 · JACC Heart Failure · 8 citations
https://doi.org/10.1016/j.jchf.2025.03.006
The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF
2025 · European Journal of Heart Failure · 6 citations
https://doi.org/10.1002/ejhf.3669
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat